Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH Agonist Plus HRT vs HRT for Endometrial Preparation in PCOS
NCT05189873Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2021
- Primary completion
- Jan 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buserelin in infertility, polycystic ovary syndrome (PCOS), sponsored by Tehran University of Medical Sciences. Started Jun 2021; status: completed.
02
Drugs
buserelin
03
Conditions
infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05189873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05189873.